Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

June 07, 2024 00:22:24
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial
Critical Care Perspectives in Emergency Medicine
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Jun 07 2024 | 00:22:24

/

Show Notes

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.

Other Episodes

Episode 0

May 26, 2020 00:27:09
Episode Cover

HFNC in COVID-19 Patients - Helpful or Harmful?

As we gain more experience managing critically ill patients with COVID-19 infection there has been a shift away from immediate intubation and towards more...

Listen

Episode 0

July 04, 2018 00:23:41
Episode Cover

Pearls for the Management Heatstroke

The heat and humidity have returned to the Northern Hemisphere!  Numerous deaths have already been reported due to the extreme heat.  In this episode...

Listen

Episode 0

January 29, 2019 00:30:02
Episode Cover

ECLS in the ED

Extracorporeal life support (ECLS) is being used with increasing frequency in many EDs across the US and across the World. In this podcast, we...

Listen